cloudfront

Report Detail

Pharma & Healthcare Global Low Molecular Weight Heparin Market Insights, Forecast to 2025

  • RnM2923642
  • |
  • 15 March, 2019
  • |
  • Global
  • |
  • 110 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Low Molecular Weight Heparin Market Insights, Forecast to 2025

Table of Contents

    Global Low Molecular Weight Heparin Market Research Report 2019-2025, by Manufacturers, Regions, Types and Applications

      1 Study Coverage

      • 1.1 Low Molecular Weight Heparin Product
      • 1.2 Key Market Segments in This Study
      • 1.3 Key Manufacturers Covered
      • 1.4 Market by Type
        • 1.4.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Type
        • 1.4.2 Enoxaparin
        • 1.4.3 Dalteparin
        • 1.4.4 Tinzaparin
        • 1.4.5 Fraxiparine
      • 1.5 Market by Application
        • 1.5.1 Global Low Molecular Weight Heparin Market Size Growth Rate by Application
        • 1.5.2 Treatment of Venous Thromboembolism
        • 1.5.3 Complications of Pregnancy
        • 1.5.4 Cardioversion of Atrial Fibrillation/Flutter
        • 1.5.5 Others
      • 1.6 Study Objectives
      • 1.7 Years Considered

      2 Executive Summary

      • 2.1 Global Low Molecular Weight Heparin Production
        • 2.1.1 Global Low Molecular Weight Heparin Revenue 2014-2025
        • 2.1.2 Global Low Molecular Weight Heparin Production 2014-2025
        • 2.1.3 Global Low Molecular Weight Heparin Capacity 2014-2025
        • 2.1.4 Global Low Molecular Weight Heparin Marketing Pricing and Trends
      • 2.2 Low Molecular Weight Heparin Growth Rate (CAGR) 2019-2025
      • 2.3 Analysis of Competitive Landscape
        • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        • 2.3.2 Key Low Molecular Weight Heparin Manufacturers
      • 2.4 Market Drivers, Trends and Issues
      • 2.5 Macroscopic Indicator
        • 2.5.1 GDP for Major Regions
        • 2.5.2 Price of Raw Materials in Dollars: Evolution

      3 Market Size by Manufacturers

      • 3.1 Low Molecular Weight Heparin Production by Manufacturers
        • 3.1.1 Low Molecular Weight Heparin Production by Manufacturers
        • 3.1.2 Low Molecular Weight Heparin Production Market Share by Manufacturers
      • 3.2 Low Molecular Weight Heparin Revenue by Manufacturers
        • 3.2.1 Low Molecular Weight Heparin Revenue by Manufacturers (2014-2019)
        • 3.2.2 Low Molecular Weight Heparin Revenue Share by Manufacturers (2014-2019)
      • 3.3 Low Molecular Weight Heparin Price by Manufacturers
      • 3.4 Mergers & Acquisitions, Expansion Plans

      4 Low Molecular Weight Heparin Production by Regions

      • 4.1 Global Low Molecular Weight Heparin Production by Regions
        • 4.1.1 Global Low Molecular Weight Heparin Production Market Share by Regions
        • 4.1.2 Global Low Molecular Weight Heparin Revenue Market Share by Regions
      • 4.2 United States
        • 4.2.1 United States Low Molecular Weight Heparin Production
        • 4.2.2 United States Low Molecular Weight Heparin Revenue
        • 4.2.3 Key Players in United States
        • 4.2.4 United States Low Molecular Weight Heparin Import & Export
      • 4.3 Europe
        • 4.3.1 Europe Low Molecular Weight Heparin Production
        • 4.3.2 Europe Low Molecular Weight Heparin Revenue
        • 4.3.3 Key Players in Europe
        • 4.3.4 Europe Low Molecular Weight Heparin Import & Export
      • 4.4 China
        • 4.4.1 China Low Molecular Weight Heparin Production
        • 4.4.2 China Low Molecular Weight Heparin Revenue
        • 4.4.3 Key Players in China
        • 4.4.4 China Low Molecular Weight Heparin Import & Export
      • 4.5 Japan
        • 4.5.1 Japan Low Molecular Weight Heparin Production
        • 4.5.2 Japan Low Molecular Weight Heparin Revenue
        • 4.5.3 Key Players in Japan
        • 4.5.4 Japan Low Molecular Weight Heparin Import & Export
      • 4.6 Other Regions
        • 4.6.1 South Korea
        • 4.6.2 India
        • 4.6.3 Southeast Asia

      5 Low Molecular Weight Heparin Consumption by Regions

      • 5.1 Global Low Molecular Weight Heparin Consumption by Regions
        • 5.1.1 Global Low Molecular Weight Heparin Consumption by Regions
        • 5.1.2 Global Low Molecular Weight Heparin Consumption Market Share by Regions
      • 5.2 North America
        • 5.2.1 North America Low Molecular Weight Heparin Consumption by Application
        • 5.2.2 North America Low Molecular Weight Heparin Consumption by Countries
        • 5.2.3 United States
        • 5.2.4 Canada
        • 5.2.5 Mexico
      • 5.3 Europe
        • 5.3.1 Europe Low Molecular Weight Heparin Consumption by Application
        • 5.3.2 Europe Low Molecular Weight Heparin Consumption by Countries
        • 5.3.3 Germany
        • 5.3.4 France
        • 5.3.5 UK
        • 5.3.6 Italy
        • 5.3.7 Russia
      • 5.4 Asia Pacific
        • 5.4.1 Asia Pacific Low Molecular Weight Heparin Consumption by Application
        • 5.4.2 Asia Pacific Low Molecular Weight Heparin Consumption by Countries
        • 5.4.3 China
        • 5.4.4 Japan
        • 5.4.5 South Korea
        • 5.4.6 India
        • 5.4.7 Australia
        • 5.4.8 Indonesia
        • 5.4.9 Thailand
        • 5.4.10 Malaysia
        • 5.4.11 Philippines
        • 5.4.12 Vietnam
      • 5.5 Central & South America
        • 5.5.1 Central & South America Low Molecular Weight Heparin Consumption by Application
        • 5.5.2 Central & South America Low Molecular Weight Heparin Consumption by Countries
        • 5.5.3 Brazil
      • 5.6 Middle East and Africa
        • 5.6.1 Middle East and Africa Low Molecular Weight Heparin Consumption by Application
        • 5.6.2 Middle East and Africa Low Molecular Weight Heparin Consumption by Countries
        • 5.6.3 Turkey
        • 5.6.4 GCC Countries
        • 5.6.5 Egypt
        • 5.6.6 South Africa

      6 Market Size by Type

      • 6.1 Global Low Molecular Weight Heparin Breakdown Dada by Type
      • 6.2 Global Low Molecular Weight Heparin Revenue by Type
      • 6.3 Low Molecular Weight Heparin Price by Type

      7 Market Size by Application

      • 7.1 Overview
      • 7.2 Global Low Molecular Weight Heparin Breakdown Dada by Application
        • 7.2.1 Global Low Molecular Weight Heparin Consumption by Application
        • 7.2.2 Global Low Molecular Weight Heparin Consumption Market Share by Application (2014-2019)

      8 Manufacturers Profiles

      • 8.1 Aspen
        • 8.1.1 Aspen Company Details
        • 8.1.2 Company Description
        • 8.1.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.1.4 Low Molecular Weight Heparin Product Description
        • 8.1.5 SWOT Analysis
      • 8.2 Sanofi-aventis
        • 8.2.1 Sanofi-aventis Company Details
        • 8.2.2 Company Description
        • 8.2.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.2.4 Low Molecular Weight Heparin Product Description
        • 8.2.5 SWOT Analysis
      • 8.3 Pfizer
        • 8.3.1 Pfizer Company Details
        • 8.3.2 Company Description
        • 8.3.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.3.4 Low Molecular Weight Heparin Product Description
        • 8.3.5 SWOT Analysis
      • 8.4 Opocrin
        • 8.4.1 Opocrin Company Details
        • 8.4.2 Company Description
        • 8.4.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.4.4 Low Molecular Weight Heparin Product Description
        • 8.4.5 SWOT Analysis
      • 8.5 CSBIO
        • 8.5.1 CSBIO Company Details
        • 8.5.2 Company Description
        • 8.5.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.5.4 Low Molecular Weight Heparin Product Description
        • 8.5.5 SWOT Analysis
      • 8.6 Dongying Tiandong Pharmaceutical
        • 8.6.1 Dongying Tiandong Pharmaceutical Company Details
        • 8.6.2 Company Description
        • 8.6.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.6.4 Low Molecular Weight Heparin Product Description
        • 8.6.5 SWOT Analysis
      • 8.7 Changzhou Qianhong Bio-pharma
        • 8.7.1 Changzhou Qianhong Bio-pharma Company Details
        • 8.7.2 Company Description
        • 8.7.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.7.4 Low Molecular Weight Heparin Product Description
        • 8.7.5 SWOT Analysis
      • 8.8 Techdow
        • 8.8.1 Techdow Company Details
        • 8.8.2 Company Description
        • 8.8.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.8.4 Low Molecular Weight Heparin Product Description
        • 8.8.5 SWOT Analysis
      • 8.9 Yantai Dongcheng Pharmaceutical Group
        • 8.9.1 Yantai Dongcheng Pharmaceutical Group Company Details
        • 8.9.2 Company Description
        • 8.9.3 Capacity, Production and Value of Low Molecular Weight Heparin
        • 8.9.4 Low Molecular Weight Heparin Product Description
        • 8.9.5 SWOT Analysis

      9 Production Forecasts

      • 9.1 Low Molecular Weight Heparin Production and Revenue Forecast
        • 9.1.1 Global Low Molecular Weight Heparin Production Forecast 2019-2025
        • 9.1.2 Global Low Molecular Weight Heparin Revenue Forecast 2019-2025
      • 9.2 Low Molecular Weight Heparin Production and Revenue Forecast by Regions
        • 9.2.1 Global Low Molecular Weight Heparin Revenue Forecast by Regions
        • 9.2.2 Global Low Molecular Weight Heparin Production Forecast by Regions
      • 9.3 Low Molecular Weight Heparin Key Producers Forecast
        • 9.3.1 United States
        • 9.3.2 Europe
        • 9.3.3 China
        • 9.3.4 Japan
      • 9.4 Forecast by Type
        • 9.4.1 Global Low Molecular Weight Heparin Production Forecast by Type
        • 9.4.2 Global Low Molecular Weight Heparin Revenue Forecast by Type

      10 Consumption Forecast

      • 10.1 Consumption Forecast by Application
      • 10.2 Low Molecular Weight Heparin Consumption Forecast by Regions
      • 10.3 North America Market Consumption Forecast
        • 10.3.1 North America Low Molecular Weight Heparin Consumption Forecast by Countries 2019-2025
        • 10.3.2 United States
        • 10.3.3 Canada
        • 10.3.4 Mexico
      • 10.4 Europe Market Consumption Forecast
        • 10.4.1 Europe Low Molecular Weight Heparin Consumption Forecast by Countries 2019-2025
        • 10.4.2 Germany
        • 10.4.3 France
        • 10.4.4 UK
        • 10.4.5 Italy
        • 10.4.6 Russia
      • 10.5 Asia Pacific Market Consumption Forecast
        • 10.5.1 Asia Pacific Low Molecular Weight Heparin Consumption Forecast by Countries 2019-2025
        • 10.5.2 China
        • 10.5.3 Japan
        • 10.5.4 Korea
        • 10.5.5 India
        • 10.5.6 Australia
        • 10.5.7 Indonesia
        • 10.5.8 Thailand
        • 10.5.9 Malaysia
        • 10.5.10 Philippines
        • 10.5.11 Vietnam
      • 10.6 Central & South America Market Consumption Forecast
        • 10.6.1 Central & South America Low Molecular Weight Heparin Consumption Forecast by Country 2019-2025
        • 10.6.2 Brazil
      • 10.7 Middle East and Africa Market Consumption Forecast
        • 10.7.1 Middle East and Africa Low Molecular Weight Heparin Consumption Forecast by Countries 2019-2025
        • 10.7.2 Middle East and Africa
        • 10.7.3 Turkey
        • 10.7.4 GCC Countries
        • 10.7.5 Egypt
        • 10.7.6 South Africa

      11 Upstream, Industry Chain and Downstream Customers Analysis

      • 11.1 Analysis of Low Molecular Weight Heparin Upstream Market
        • 11.1.1 Low Molecular Weight Heparin Key Raw Material
        • 11.1.2 Typical Suppliers of Key Low Molecular Weight Heparin Raw Material
        • 11.1.3 Low Molecular Weight Heparin Raw Material Market Concentration Rate
      • 11.2 Low Molecular Weight Heparin Industry Chain Analysis
      • 11.3 Marketing & Distribution
      • 11.4 Low Molecular Weight Heparin Distributors
      • 11.5 Low Molecular Weight Heparin Customers

      12 Opportunities & Challenges, Threat and Affecting Factors

      • 12.1 Market Opportunities
      • 12.2 Market Challenges
      • 12.3 Porter's Five Forces Analysis

      13 Key Findings

        14 Appendix

        • 14.1 Research Methodology
          • 14.1.1 Methodology/Research Approach
          • 14.1.2 Data Source
        • 14.2 Author Details

        Low Molecular Weight Heparin (LMWHs) is derived from UFH (Unfractionated heparin) by such processes as chemical degradation, enzymatic depolymerisation and gamma-radiation cleavage.
        Natural heparin consists of molecular chains of varying lengths, or molecular weights. Chains of varying molecular weights, from 5000 to over 40,000 Daltons, make up polydisperse pharmaceutical-grade heparin. LMWHs, in contrast, consist of only short chains of polysaccharide. LMWHs are defined as heparin salts having an average molecular weight of less than 8000 Da and for which at least 60% of all chains have a molecular weight less than 8000 Da.
        In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second’s largest market with the share of 30.49%.
        At present, the major manufacturers of Low Molecular Weight Heparin are Aspen, Sanofi-aventis, Pfizer, Opocrin, CSBIO, Dongying Tiandong Pharmaceutical, Changzhou Qianhong Bio-pharma, Techdow, Yantai Dongcheng Pharmaceutical Group, etc. Aspen, Sanofi-aventis and Pfizer are industry-leading manufacturers of top-quality Low Molecular Weight Heparins.
        China is a big low molecular weight heparin production country, especially Heparin API, but it is not strong country. According to our research and analysis, manufacturers from United States and Europe are the major leaders in the international market of low molecular weight heparin. Manufacturers from China are immature in technology. There is large space in the China market, as well as big gap between international brands and local brands on price.
        In application, low molecular weight heparin downstream is wide and recently low molecular weight heparin has acquired increasing significance in various fields of treatment of venous thromboembolism, complications of pregnancy, cardioversion of atrial fibrillation/flutter and others.
        Globally, the low molecular weight heparin market is mainly driven by growing demand for treatment of venous thromboembolism which accounts for nearly 65.24% of total downstream consumption of low molecular weight heparin in global.
        Global Low Molecular Weight Heparin market size will increase to 410 Million US$ by 2025, from 270 Million US$ in 2018, at a CAGR of 5.4% during the forecast period. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Low Molecular Weight Heparin.

        This report researches the worldwide Low Molecular Weight Heparin market size (value, capacity, production and consumption) in key regions like United States, Europe, Asia Pacific (China, Japan) and other regions.
        This study categorizes the global Low Molecular Weight Heparin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

        The following manufacturers are covered in this report:
        Aspen
        Sanofi-aventis
        Pfizer
        Opocrin
        CSBIO
        Dongying Tiandong Pharmaceutical
        Changzhou Qianhong Bio-pharma
        Techdow
        Yantai Dongcheng Pharmaceutical Group

        Low Molecular Weight Heparin Breakdown Data by Type
        Enoxaparin
        Dalteparin
        Tinzaparin
        Fraxiparine
        Low Molecular Weight Heparin Breakdown Data by Application
        Treatment of Venous Thromboembolism
        Complications of Pregnancy
        Cardioversion of Atrial Fibrillation/Flutter
        Others

        Low Molecular Weight Heparin Production Breakdown Data by Region
        United States
        Europe
        China
        Japan
        Other Regions

        Low Molecular Weight Heparin Consumption Breakdown Data by Region
        North America
        United States
        Canada
        Mexico
        Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Malaysia
        Philippines
        Thailand
        Vietnam
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Rest of Europe
        Central & South America
        Brazil
        Rest of South America
        Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa
        Rest of Middle East & Africa

        The study objectives are:
        To analyze and research the global Low Molecular Weight Heparin capacity, production, value, consumption, status and forecast;
        To focus on the key Low Molecular Weight Heparin manufacturers and study the capacity, production, value, market share and development plans in next few years.
        To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
        To define, describe and forecast the market by type, application and region.
        To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
        To identify significant trends and factors driving or inhibiting the market growth.
        To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
        To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
        To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
        To strategically profile the key players and comprehensively analyze their growth strategies.

        In this study, the years considered to estimate the market size of Low Molecular Weight Heparin :
        History Year: 2014-2018
        Base Year: 2018
        Estimated Year: 2019
        Forecast Year 2019 to 2025
        For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


        Summary:
        Get latest Market Research Reports on Low Molecular Weight Heparin . Industry analysis & Market Report on Low Molecular Weight Heparin is a syndicated market report, published as Global Low Molecular Weight Heparin Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Low Molecular Weight Heparin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,900.00
        $5,850.00
        $7,800.00
        2,618.85
        3,928.28
        5,237.70
        3,588.78
        5,383.17
        7,177.56
        472,446.00
        708,669.00
        944,892.00
        258,622.26
        387,933.39
        517,244.52
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report